| Schedule of Segment Information |
Schedule of Segment Information
| |
|
2025 |
|
|
2024 |
|
| |
|
Years
ended September 30, |
|
| |
|
2025 |
|
|
2024 |
|
| Research and development: |
|
|
|
|
|
|
|
|
| Clinical |
|
$ |
5,632,217 |
|
|
$ |
2,613,188 |
|
| Non-clinical |
|
|
2,260,300 |
|
|
|
3,888,787 |
|
| Other(1) |
|
|
462,787 |
|
|
|
(764,723 |
) |
| Total
research and development |
|
|
8,355,304 |
|
|
|
5,737,252 |
|
| General and administrative: |
|
|
|
|
|
|
|
|
| Payroll and related |
|
|
1,716,552 |
|
|
|
715,846 |
|
| Professional fees |
|
|
3,695,790 |
|
|
|
1,922,292 |
|
| Consulting |
|
|
1,314,698 |
|
|
|
1,532,601 |
|
| Other(2) |
|
|
1,761,771 |
|
|
|
1,960,106 |
|
| Total
general and administrative |
|
|
8,488,811 |
|
|
|
6,130,845 |
|
| Operating
expenses |
|
$ |
16,844,115 |
|
|
$ |
11,868,097 |
|
| (1)
|
Other
research and development consists primarily of payroll and related expenses and dues, licenses and subscriptions. The balance is
negative for the year ended September 30, 2024 due to the cancellation of accrued but unpaid bonuses that had been awarded for fiscal
years 2022 and 2023. |
| (2) |
Other
general and administrative consists primarily of facilities, insurance, filing fees, travel expenses and franchise taxes. |
|